Genetics of attention deficit/hyperactivity disorder (ADHD)

DSMIV-TR workgroup. 2000. The Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision. Washington, DC: American Psychiatric Association.

Linnet KM, Dalsgaard S, Obel C, Wisborg K, Henriksen TB, Rodriguez A, Kotimaa A, Moilanen I, Thomsen PH, Olsen J, Jarvelin MR. 2003. Maternal lifestyle factors in pregnancy risk of attention-deficit/hyperactivity disorder and associated behaviors: review of the current evidence. American Journal of Psychiatry 160(6), 1028-1040.

Mick E, Biederman J, Faraone SV, Sayer J, Kleinman S. 2002. Case-control study of attention deficit hyperactivity disorder and maternal smoking, alcohol use, and drug use during pregnancy. Journal of the American Academy of Child and Adolescent Psychiatry 41(4), 378-385.

Meltzer  H,  Gatward  R,  Goodman  R.  2003. Mental health of children and adolescents in Great Britain. Int Rev Psychiatry 15, 185–187.

McCann D, Barrett A, Cooper A. 2007. Food additives and hyperactive behaviour in 3-year-old and 8/9-year-old children in the community: a randomised, double-blinded, placebo-controlled trial. Lancet 370(9598), 1560-1567.

Lionel C, Crosbie J, Barbosa N, Goodale T. 2011. Rare Copy Number Variation Discovery and Cross-Disorder Comparisons Identify Risk Genes for ADHD. Science Translational Medicine 3 (95), 95ra75.

Nigel M Williams, Irina Zaharieva, Andrew Martin, Kate Langley, Kiran Mantripragada. 2010. Rare chromosomal deletions and duplications in attention-deficit hyperactivity disorder: a genome-wide analysis. The Lancet 376(9750), 1401–1408.

Braun J, Kahn RS, Froehlich T, Auinger P, Lanphear BP. 2006. Exposures to environmental toxicants and attention-deficit/hyperactivity disorder in U.S. children. Environmental Health Perspectives 114(12), 1904-1909

Corbett B. 2006. Constantine L. Autism and Attention Deficit Hyperactivity Disorder: Assessing Attention and Response Control with the Integrated Visual and Auditory Continuous Performance Test. Child Neuropsychology (Neuropsychology, Development and Cognition: Section C) 12(4-5), 335-348.

Leyfer OT, Folstein SE, Bacalmaan S, Davis NO, Dinh E, Morgan J. 2006. Comorbid psychiatric disorders in children with autism: interview development and rates of disorders. Journal of Autism and Developmental Disorders 36, 849-861.

Sturm H, Fernell E, Gillberg C. 2004. Autism spectrum disorders in children with normal intellectual levels: Associated impairments and subgroups. Developmental Medicine and Child Neurology 46, 444-447.

Clark DB, Parker A, lynch K. 1999. Psycopathology and substance related problems during early adolescence: A survival analysis. Journal of clinical child psychology 28, 333-341.

Geurts HM, Vert´e S, Oosterlaan J, Roeyers H, Sergeant JA. 2004. Howspecific are executive functioning deficits in attention deficit hyperactivity disorder and autism? Journal of Child Psychology and Psychiatry 45, 836–854.

Albin RL, Mink JW. 2006. Recent advances In Tourette syndrome research.Trends neurosci 29,175-182.

Qunitana H. 1995. Use of methylphenidate in the treatment of children with autistic disorder. J Aut Develop Disord 25, 283-94.

Nair J, Ehimare U, Beitman BD, Nair SS, Lavin A. 2006. Clinical review: evidence-based diagnosis and treatment of ADHD in children. Mol Med 03 (6), 617–621.

Kerstin Konrad, Siegfried Gauggel, Andrea Manz, Melanie Schöll. 2006. Inhibitory control in children with traumatic brain injury (TBI) and children with attention deficit/hyperactivity disorder (ADHD). Brain Injury 14(10), 859-875.

Arcos-Burgos M. 2010. A common variant of the latrophilin 3 gene, LPHN3, confers Susceptibility to ADHD and predicts effectiveness of stimulant medication. Mol Psychiatry 15(11), 1053-1066.

Kanner L. 1943. Autistic disturbances of affective contact. Nervous Child 2, 217– 250.

DSM-III. 1980. Diagnostic and statistical manual of mental disorders. 3rd ed. Arlington, VA: American Psychiatric Association, 567.

Faraone SV, Perlis RH, Doyle AE, Smoller JW, Goralnick JJ, Holmgren MA, Sklar P. 2005. Molecular genetics of attention-deficit/hyperactivity disorder. Biological Psychiatry 57, 1313-1323.

Khan SA, Faraone SV. 2006. The genetics of attention-deficit/hyperactivity disorder: A literature review of 2005. Current Psychiatry Reports 8, 393-397.

Shaw P, Gornick M, Lerch J, Addington A, Seal J, Greenstein D, Sharp W, Evans A, Giedd JN, Castellanos FX, Rapoport JL. 2007. Polymorphisms of the dopamine D4 receptor, clinical outcome and cortical structure in attention-deficit/hyperactivity disorder. Archives of General Psychiatry 64(8), 921-931.

Linnet KM, Dalsgaard S, Obel C. 2003. Maternal lifestyle factors in pregnancy risk of attention-deficit/hyperactivity disorder and associated behaviors: review of the current evidence. American Journal of Psychiatry 160(6), 1028-1040.

Mick E, Biederman J, Faraone SV, Sayer J, Kleinman S. 2002. Case-control study of attention-deficit hyperactivity disorder and maternal smoking, alcohol use, and drug use during pregnancy. Journal of the American Academy of Child and Adolescent Psychiatry 41(4), 378-385.

Braun J, Kahn RS, Froehlich T, Auinger P, Lanphear BP. 2006. Exposures to environmental toxicants and attention-deficit/hyperactivity disorder in U.S. children. Environmental Health Perspectives 114(12), 1904-1909.

Wolraich M, Milich R, Stumbo P, Schultz F. 1985. The effects of sucrose ingestion on the behavior of hyperactive boys. Pediatrics 106(4), 657-682.

Wolraich ML, Lindgren SD, Stumbo PJ, Stegink LD, Appelbaum MI, Kiritsy MC. 1994. Effects of diets high in sucrose or aspartame on the behavior and cognitive performance of children. New England Journal of Medicine 330(5), 301-307.

Hoover DW, Milich R. 1994. Effects of sugar ingestion expectancies on mother-child interaction. Journal of Abnormal Child Psychology 22, 501-515.

McCann D, Barrett A, Cooper A. 2007. Food additives and hyperactive behaviour in 3-year-old and 8/9-year-old children in the community: a randomised, double-blinded, placebo-controlled trial. Lancet 370(9598), 1560-1567.

Daniels JL. 2006. Autism  and  the  environment. Environ Health Perspect 114, A396.

Kidd PM. 2000. Attention deficit/hyperactivity disorder (ADHD) in children: Rationale for Its integrative management. Altern Med Rev 5, 402–428.

Happe F, Ronald A, Plomin R. 2006. Time to give up on a single explanation for autism. Nature Neurosci 9, 1218–1220.

Hertz-Picciotto I, Croen LA, Hansen R,.2006. The charge Study: An epidemiologic Investigation of genetic and environmental factors contributing to autism. Environ Health Perspect 114, 1119–1125.

Steer CR. 2005. Managing attention deficit disorder: Unmet needs and future directions. Arch Dis Child 90, S19–S25.

Parker JG. & Asher SR. 1987. Peer relations and later personal adjustment: are low-accepted children at risk?. Psychol Bull 102, 357–389.

Hoza B, Mrug S, Gerdes AC. 2005. What aspects of peer relationships are impaired in children with attention-deficit/hyperactivity disorder? J Consult Clin Psychol 73, 411–423.

Gresham FM, & Elliott SN. 1989. Social Skills Rating System—Parent, Teacher, and Child Forms. Circle Pines, MN: American Guidance Systems.

Achenbach TM, McConaughy SH, & Howell CT. 1987. Child/adolescent behavioral and emotional problems: implications of crossinformant correlations for situational specificity. Psychol Bull 101, 213–232.

Mulligan A, Anney RJL, O’Regan M, Chen W, Butler L, Fitzgerald M. 2009. Autism symptoms in Attention-Deficit/Hyperactivity Disorder: A Familial trait which Correlates with Conduct, Oppositional Defiant, Language and Motor Disorders. Journal of Autism and Developmental Disorders 39, 197–209.

Nijmeijer JS, Hoekstra PJ, Minderaa RB, Buitelaar JK, Altink ME, Buschgens CJ. 2009. PDD symptoms in ADHD, an independent familial trait? Journal of Abnormal Child Psychology 37, 443– 453.

Carpenter RE, Loo SK, Yang M, Dang J, Smalley SL. 2009. Social functioning difficulties in ADHD: association with PDD risk. Clinical Child Psychology & Psychiatry 14, 329–344.

Bagwell CL, Molina BS, Pelham WE Jr, Hoza B. 2001. Attention-deficit hyperactivity disorder and problems in peer relations: predictions from childhood to adolescence. Journal of the American Academy of Child and Adolescent Psychiatry 40, 1285–1292.

McQuade JD, Hoza B. 2008. Peer problems in Attention Deficit Hyperactivity Disorder: current status and future directions. Developmental Disabilities and Research Reviews 14, 320–324.

Fombonne E, Simmons H, Ford T, Meltzer H, Goodman R. 2001. Prevalence of pervasive developmental disorders in the British nationwide survey of child mental health. Journal of the American Academy of Child and Adolescent Psychiatry 40, 820-827.

Deeann Wallis, Heather F, Russell, Maximilian Muenke. 2008. Review: Genetics of Attention Deficit/Hyperactivity Disorder Journal of Pediatric Psychology 33(10), 1085–1099.

Bobb A, Castellanos F, Addington A, Rapoport J. 2004. Molecular genetic studies of ADHD: 1991 to 2004. American Journal of Medical Genetics 132, 109–125.

Comings DE, Gade-Andavolu R, Gonzalez N, Wu S, Muhleman D, Blake H. et al. 2000. Multivariate analysis of associations of 42 genes in ADHD, ODD and conduct disorder. Clinical Genetics 58, 31–40.

Guan L, Wang B, Chen Y, Yang L, Li J, Qian Q. 2008. A high-density single-nucleotide polymorphism screen of 23 candidate genes in attention deficit hyperactivity disorder: Suggesting multiple susceptibility genes among Chinese Han population. Molecular Psychiatry.

Amara S, Kuhar M. 1993. Neurotransmitter transporters: Recent progress. Annual Review of Neuroscience 16, 73–93.

Faraone SV, Doyle AE, Mick E, Biederman J. 2001. Meta-analysis of the association between the 7-repeat allele of the dopamine D(4) receptor gene and attention deficit hyperactivity disorder. American Journal of Psychiatry 158, 1052–1057.

Grevet EH, Marques FZ, Salgado CA, Fischer AG, Kalil KL, Victor MM. 2007. Serotonin transporter gene polymorphism and the phenotypic heterogeneity of adult ADHD. Journal of Neural Transmission 114, 1631–1636.

Seeger G, Schloss P, Schmidt MH. 2001. Functional polymorphism within the promotor of the serotonin transporter gene is associated with severe hyperkinetic disorders. Molecular Psychiatry 6, 235– 238.

O’Neill M, Heron-Maxwell C, Shaw G. 1999. 5-HT2 receptor antagonism reduces hyperactivity induced by amphetamine, cocaine, and MK-801 but not D1 agonist C-APB. Pharmacology Biochemistry, and Behavior 63, 237–243.

Barr C, Feng Y, Wigg K, Bloom S, Roberts W, Malone M. 2000. Identification of DNA variants in the SNAP-25 gene and linkage study of these polymorphisms and attention-deficit hyperactivity disorder. Molecular Psychiatry 5, 405–409.

Kim JW, Biederman J, Arbeitman L, Fagerness J, Doyle AE, Petty C. 2007. Investigation of variation in SNAP-25 and ADHD and relationship to co-morbid major depressive disorder. American Journal of Medical Genetics Part B (Neuropsychiatric Genetics) 144, 781–790.

Eisenberg J, Mei-Tal G, Steinberg A, Tartakovsky E, Zohar A, Gritsenko I. 1999. Haplotype relative risk study of catechol-O-methyltransferase (COMT) and attention deficit hyperactivity disorder (ADHD): Association of the high-enzyme activity Val allele with ADHD impulsive-hyperactive phenotype. American Journal of Medical Genetics 88, 497–502.

Ogdie MN, Macphie IL, Minassian SL, Yang M, Fisher SE, Francks C. 2003. A genomewide scan for attention-deficit/hyperactivity disorder in an extended sample: suggestive linkage on 17p11. American Journal of Human Genetics 72(5), 1268-1279.

Ogdie MN, Fisher SE, Yang M, Ishii J, Francks C, Loo SK. 2004. Attention deficit hyperactivitydisorder: Fine mapping supports linkage to 5p13, 6q12,16p13, and 17p11. American Journal of Human Genetics 75, 661–668.

Bakker SC, van der Meulen EM, Buitelaar JK, Sandkuijl LA, Pauls DL, Monsuur AJ. 2003. A whole-genome scan in 164 Dutch sib pairs with attention-deficit/hyperactivity disorder: Suggestive evidence for linkage on chromosomes 7p and 15q. American Journal of Human Genetics 72, 1251–1260.

Arcos-Burgos M, Castellanos FX, Pineda D, Lopera F, Palacio JD, Palacio LG. 2004. Attention-deficit/hyperactivity disorder in a population isolate: Linkage to loci at 4q13.2, 5q33.3, 11q22, and 17p11. American Journal of Human Genetics 75, 998–1014.

Hebebrand J, Dempfle A, Saar K, Thiele H, Herpertz-Dahlmann B, Linder M. 2006. A genome-wide scan for attention-deficit/hyperactivity disorder in 155 German sib-pairs. Molecular Psychiatry 11, 196–205.

Loe IM, Feldman HM. 2007. Academic and educational outcomes of children with ADHD. J Pediatr Psychol 32, 643-654.

Pelham WE, Fabiano GA. 2007. State University of New York at Buffalo: Evidence-based psychosocial treatment for attention-deficit/ hyperactivity disorder: An update. Journal of Clinical Child and Adolescent Psychology.

Erik Parens and Josephine Johnston. 2009. Facts, values, and Attention-Deficit Hyperactivity Disorder (ADHD): an update on the controversies Child and Adolescent Psychiatry and Mental Health 3:1.

Daley D. 2006. Attention deficit hyperactivity disorder: A review of the essential facts. Child Care Health Dev 32, 193–204.

Steer CR. 2005. Managing attention deficit disorder: Unmet needs and future directions. Arch Dis Child 90, S19–S25.

Campbell-Daley K. 2004. Update on attention-deficit hyperactivity disorder. Curr Opin Pediatr, 16, 217–226.

Daly BP, Creed T, Xanthopolous M, Brown RT. 2007. Psychosocial treatments for children with attention deficit/ hyperactivity disorder. Neuropsychol Res 17, 73–89.

Voeller KK. 2004. Attention-deficit  hyperactivity disorder (ADHD). J Child Neurol 19, 798–814.

Kidd  PM.  2000.  Attention  deficit/hyperactivity disorder  (ADHD)  in  children:  Rationale  for  its integrative management. Altern Med Rev 5, 402–428.